Polypharmacy among inpatients aged 70 years or older in Australia

Medical Journal of Australia

Volumn 202, Issue 7, 2015, Pages 373-378

  Hubbard, Ruth E ^a   Peel, Nancye M ^a   Scott, Ian A ^a,b   Martin, Jennifer H ^a,c   Smith, Alesha ^a   Pillans, Peter I ^b   Poudel, Arjun ^a   Gray, Leonard C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROLEPTIC AGENT; OPIATE;

AGED; AGING; ARTICLE; AUSTRALIA; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; DAILY LIFE ACTIVITY; DYSPNEA; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERPOLYPHARMACY; ISCHEMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PAIN; POLYPHARMACY; PRESCRIPTION; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SOCIAL PSYCHOLOGY; VERY ELDERLY; HEALTH STATUS INDICATOR; HOSPITALIZATION; RISK;

AGED; AGED, 80 AND OVER; AUSTRALIA; FEMALE; HEALTH STATUS INDICATORS; HOSPITALIZATION; HUMANS; MALE; ODDS RATIO; PATIENT ADMISSION; PATIENT DISCHARGE; POLYPHARMACY; PROSPECTIVE STUDIES;

EID: 84930700284     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.00172     Document Type: Article

References (24)

1. 1 Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012; 65: 989-995.
2. 2 Bellelli G, Magnifico F, Trabucchi M. Outcomes at 12 months in a population of elderly patients discharged from a rehabilitation unit. J Am Med Dir Assoc 2008; 9: 55-64.
3. 3 Egger SS, Bachmann A, Hubmann N, et al. Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards. Drugs Aging 2006; 23: 823-837.
4. 4 Wahab MS, Nyfort-Hansen K, Kowalski SR. Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria. Int J Clin Pharm 2012; 34: 855-862.
5. 5 Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013-1019.
6. 6 Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLOS One 2009; 4: e4439.
7. 7 Sanossian N, Ovbiagele B. Prevention and management of stroke in very elderly patients. Lancet Neurol 2009; 8: 1031-1041.
8. Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 2015; Mar 23. [Epub ahead of print.]
9. 9 Hubbard RE, O’Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol 2013; 69: 319-326.
10. 10 Brand CA, Martin-Khan M, Wright O, et al. Development of quality indicators for monitoring outcomes of frail elderly hospitalised in acute care health settings: study protocol. BMC Health Serv Res 2011; 11: 281.
11. 11 Lakhan P, Jones M, Wilson A, et al. A prospective cohort study of geriatric syndromes among older medical patients admitted to acute care hospitals. J Am Geriatr Soc 2011; 59: 2001-2008.
12. 12 Travers C, Byrne G, Pachana N, et al. Prospective observational study of dementia and delirium in the acute hospital setting. Intern Med J 2013; 43: 262-269.
13. 13 Gray L, Ariño-Blasco S, Berg K, et al. InterRAI acute care (AC) assessment form and user’s manual. Washington, DC: interRAI, 2010.
14. 14 Gray LC, Bernabei R, Berg K, et al. Standardizing assessment of elderly people in acute care: the interRAI Acute Care instrument. J Am Geriatr Soc 2008; 56: 536-541.
15. 15 Gray L, Ariño-Blasco S, Berg K, et al. InterRAI clinical and management applications manual for use with the interRAI acute care assessment instrument. Version 9.1. Washington, DC: interRAI, 2013.
16. 16 Currow DC, Stevenson JP, Abernethy AP, et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007; 55: 590-595.
17. 17 Lee HR, Yi SY, Kim do Y. Evaluation of prescribing medications for terminal cancer patients near death: essential or futile. Cancer Res Treat 2013; 45: 220-225.
18. 18 Onder G, Liperoti R, Fialova D, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci 2012; 67: 698-704.
19. 19 von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
20. Australian Commission on Safety and Quality in Health Care. Taking a best possible medication history. http://www.safetyandquality.gov.au/our-work/medication-safety/medication-reconciliation/takinga-best-possible-medication-history (accessed May 2013).
21. 21 Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother 2011; 9: 378-391.
22. 22 Rockwood K, Joyce B, Stolee P. Use of goal attainment scaling in measuring clinically important change in cognitive rehabilitation patients. J Clin Epidemiol 1997; 50: 581-588.
23. 23 Fried TR, Tinetti ME, Towle V, et al. Effects of benefits and harms on older persons’ willingness to take medication for primary cardiovascular prevention. Arch Intern Med 2011; 171: 923-928.
24. 24 Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care – the POLYMED randomised controlled trial. Age Ageing 2007; 36: 292-297.